Gharib H, Papini E, Paschke R
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA.
Eur J Endocrinol. 2008 Nov;159(5):493-505. doi: 10.1530/EJE-08-0135. Epub 2008 Aug 26.
In 2006, two major society-sponsored guidelines and one major consensus statement for thyroid diagnosis and management were published by: the American Association of Clinical Endocrinologists/Associazione Medici Endocrinologi (AACE/AME); the American Thyroid Association (ATA); and the European Thyroid Association (ETA). A careful review of these guidelines reveals that despite many similarities, significant differences are also present, likely reflecting differences in practice patterns, interpretation of existing data, and availability of resources in different regions. The methodology of the guidelines is similar, but a few differences in the rating scale make a rapid comparison of the strength of both evidence and recommendations difficult for the use in current clinical practice. Some recommendations are based mostly on experts' opinion. Thus, a same recommendation may be based on a different evidence; on the other hand, sometimes the same evidence may induce a different recommendation. Therefore, efforts are needed to produce a few high-quality clinical studies to close the evidence gaps in the still controversial fields of thyroid disease and to create a joint task force of the most authoritative societies in the field of thyroid disease in order to reach a common document for clinical practice recommendations.
2006年,美国临床内分泌医师协会/内分泌医师协会(AACE/AME)、美国甲状腺协会(ATA)以及欧洲甲状腺协会(ETA)发布了两份主要的由协会赞助的甲状腺诊断和管理指南以及一份主要的共识声明。仔细审视这些指南会发现,尽管它们有许多相似之处,但也存在显著差异,这可能反映出不同地区在实践模式、对现有数据的解读以及资源可获取性方面的差异。这些指南的方法学是相似的,但评级量表上的一些差异使得在当前临床实践中难以快速比较证据和推荐意见的力度。一些推荐意见大多基于专家意见。因此,同样的推荐意见可能基于不同的证据;另一方面,有时同样的证据可能会得出不同的推荐意见。所以,需要开展一些高质量的临床研究来填补甲状腺疾病仍存在争议领域的证据空白,并组建一个由甲状腺疾病领域最具权威性的协会组成的联合工作组,以便达成一份临床实践推荐的共同文件。